Adalat® is one of the best researched blood-lowering drugs. Clinical studies such as, INSIGHT and ACTION have clearly shown that Adalat® can help optimise blood pressure control and prevent long-term cardiovascular damage. Adalat® was the first calcium channel blocker to be shown to significantly reduce the development of new overt heart failure in patients with coronary artery disease. Excellent blood-pressure control in recent clinical trials has been shown to result in significant protection against stroke.1,2
Scientific evidence shows that Adalat® has some of the best results for long-term clinical outcome. Thus, large-scale, controlled clinical trials have confirmed that Adalat® can delay disease progression in patients with high blood pressure: Adalat® can save lives.1,2
1. Brown MJ, et al. Lancet 2000;356:366–72.
2. Poole-Wilson P, et al. Lancet 2004;364:849–57.
